2012
Association Between Sentinel Lymph Node Excision With or Without Preoperative SPECT/CT and Metastatic Node Detection and Disease-Free Survival in Melanoma
Search citation statements
Paper Sections
Select...
116
21
6
2
Citation Types
3
75
0
5
Year Published
2000
2026
Publication Types
Select...
109
24
4
1
Relationship
7
131
Authors
Journals
Cited by 137 publications
(83 citation statements)
References 29 publications
3
75
0
5
“…The authors showed SPECT/CT identified more SLNs compared to PLS, 2.40 versus 1.87, respectively ( p < 0.001). 1 This finding was consistent with previous, smaller studies. 11, 12 The authors concluded the potential advantages of SPECT/CT encompassed additional three-dimensional anatomic detail, which could assist in more accurate placement of the surgical incision allowing the surgeon to identify the SLN with less dissection and overall less morbidity.…”
supporting
confidence: 93%
“…The authors showed SPECT/CT identified more SLNs compared to PLS, 2.40 versus 1.87, respectively ( p < 0.001). 1 This finding was consistent with previous, smaller studies. 11, 12 The authors concluded the potential advantages of SPECT/CT encompassed additional three-dimensional anatomic detail, which could assist in more accurate placement of the surgical incision allowing the surgeon to identify the SLN with less dissection and overall less morbidity.…”
supporting
confidence: 93%
“…They detected with SPECT/CT significantly more SLNs per patient than with planar imaging alone leading to a significantly higher rate of identified metastatic SLNs per patient with SPECT/CT (17). With SPECT/CT significantly fewer patients had a local relapse than with planar imaging alone, which prolonged 4-year disease-free survival (17). In the present study, we could confirm these findings.…”
Section: Discussionsupporting
confidence: 77%
“…The number of positive SLN per patient was significantly higher in the SPECT/CT cohort (0.34 vs 0.21; p = 0.038). The local relapse rate in the SPECT/CT cohort was lower than in the standard cohort (6.8% vs 23.8%, p = 0.021), which prolonged disease-free survival ( p = 0.019) [14]. This study confirms the improved identification of SLN in overweight and obese melanoma patients [17] as well as those with tumors in the head and neck area [18, 19].…”
Section: Introductionsupporting
confidence: 62%
